Tag Archives: John Newman

Analysts Are Bullish on These Healthcare Stocks: Regeneron (REGN), Aptose Biosciences (APTO)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Regeneron (REGN – Research Report), Aptose Biosciences (APTO – Research Report) and scPharmaceuticals (SCPH – Research Report) with bullish sentiments. Regeneron (REGN)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sesen Bio (NASDAQ: SESN) and Amphastar Pharmaceuticals (NASDAQ: AMPH)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sesen Bio (SESN – Research Report) and Amphastar Pharmaceuticals (AMPH – Research Report). Sesen Bio (SESN) Canaccord Genuity analyst John Newman maintained a

Histogen (HSTO) Has a New Rating from Canaccord Genuity

Histogen (HSTO – Research Report) received a Buy rating and a $5.00 price target from Canaccord Genuity analyst John Newman today. The company’s shares closed last Wednesday at $1.17, close to its 52-week low of $0.75. According to TipRanks.com, Newman

Canaccord Genuity Maintains Their Buy Rating on Kaleido Biosciences (KLDO)

Canaccord Genuity analyst John Newman maintained a Buy rating on Kaleido Biosciences (KLDO – Research Report) yesterday and set a price target of $19.00. The company’s shares closed last Wednesday at $9.82. According to TipRanks.com, Newman is a 5-star analyst

Analysts Offer Insights on Healthcare Companies: Regeneron (NASDAQ: REGN) and Cassava Sciences (NASDAQ: SAVA)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Regeneron (REGN – Research Report) and Cassava Sciences (SAVA – Research Report) with bullish sentiments. Regeneron (REGN) Canaccord Genuity analyst John Newman

Palatin Technologies (PTN) Receives a Buy from Canaccord Genuity

In a report released yesterday, John Newman from Canaccord Genuity maintained a Buy rating on Palatin Technologies (PTN – Research Report), with a price target of $3.00. The company’s shares closed last Wednesday at $0.92. According to TipRanks.com, Newman is